drugset
Drugs / Zicronapine
last change Oct 2012 re-read 2 minutes ago

Zicronapine

also known as LU-31-130 · LU-31130 SUCCINATE · Zicronapina · ZICRONAPINE SUCCINATE

Small molecule

Developed for
schizophrenia
Investigated by
H. Lundbeck A/S

Trials 4 · a red edge is where a trial was stopped

today NCT01377233 · Ph 2 NCT01295372 · Ph 3 NCT00770744 · Ph 2 NCT00768326 · Ph 2
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 23 trials
Phase 2 NCT01377233 Jul 2011 → Feb 2012 schizophrenia H. Lundbeck A/S Completed No outcome recorded
Phase 2 NCT00770744 Sep 2008 → Oct 2009 schizophrenia H. Lundbeck A/S Completed No outcome recorded
Phase 2 NCT00768326 Mar 2007 → Oct 2009 schizophrenia H. Lundbeck A/S Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01295372 Apr 2011 → Oct 2012 schizophrenia H. Lundbeck A/S Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Zicronapine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00770744 ↗
3

NCT00768326 ↗

NCT01295372 ↗

NCT01377233 ↗
Known as LU-31-130 ChEMBL registry synonym — accepted as the source's own label CHEMBL3039528 ↗
Known as LU-31130 SUCCINATE ChEMBL registry synonym — accepted as the source's own label CHEMBL3039528 ↗
Known as Zicronapina ChEMBL registry synonym — accepted as the source's own label CHEMBL3039528 ↗
Known as ZICRONAPINE SUCCINATE ChEMBL registry synonym — accepted as the source's own label CHEMBL3039528 ↗
Modality Small molecule — CHEMBL3039528 ↗
Route Oral “3mg; orally, film-coated tablets, once daily, 8 weeks” NCT00768326 ↗